{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:49:41Z","timestamp":1779936581388,"version":"3.53.1"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,25]],"date-time":"2015-01-25T00:00:00Z","timestamp":1422144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s00482-014-1463-x","type":"journal-article","created":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T18:28:52Z","timestamp":1422037732000},"page":"109-130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Empfehlungen der aktualisierten Leitlinie LONTS","Recommendations of the updated LONTS guidelines"],"prefix":"10.1007","volume":"29","author":[{"given":"W.","family":"H\u00e4user","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Engeser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Hege-Scheuing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"H\u00fcppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lindena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Norda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Radbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sabatowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schiltenwolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Sorgatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"T\u00f6lle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Willweber-Strumpf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Petzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,25]]},"reference":[{"key":"1463_CR1","first-page":"485272","volume":"2013","author":"Ablin","year":"2013","unstructured":"Ablin J, Fitzcharles MA, Buskila D et\u00a0al (2013) Treatment of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines with special emphasis on complementary and alternative therapies. Evid Based Complement Alternat Med 2013:485272","journal-title":"Evid Based Complement Alternat Med"},{"key":"1463_CR2","doi-asserted-by":"crossref","unstructured":"Allan L, Richarz U, Simpson K, Slappendel\u00a0R (2005) Transdermal fentanyl versus sustained release oral morphine in strong-opioid na\u00efve patients with chronic low back pain. Spine (Phila Pa 1976) 30(22):2484\u20132490","DOI":"10.1097\/01.brs.0000186860.23078.a8"},{"key":"1463_CR3","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), \u00c4rztliches Zentrum f\u00fcr Qualit\u00e4t in der Medizin (\u00c4ZQ) (2006) Deutsches Instrument zur methodischen Leitlinienbewertung (DELBI). Z\u00a0\u00c4rztl Fortbild Qual Gesundhwes 99:468\u2013492"},{"key":"1463_CR4","unstructured":"Arzneimittelkommission der Deutschen \u00c4rzteschaft. Rote Hand Brief Flupirtin. http:\/\/www.akdae.de\/Arzneimittelsicherheit\/RHB\/Archiv\/2013\/20130716.pdf. Zugegriffen: 28.\u00a0August 2014"},{"key":"1463_CR5","unstructured":"Arzneimittelkommission der Deutschen \u00c4rzteschaft. Diclofenac \u2013 Neue Kontraindikationen und Warnhinweise nach europaweiter \u00dcberpr\u00fcfung der kardiovaskul\u00e4ren Sicherheit. http:\/\/www.akdae.de\/Arzneimittelsicherheit\/RHB\/Archiv\/2013\/20130715.pdf"},{"key":"1463_CR6","first-page":"A724","volume":"109","author":"Arzneimittelkommission","year":"2012","unstructured":"Arzneimittelkommission der Deutschen \u00c4rzteschaft (2012) Die unkritische Anwendung von Fentanylpflastern erh\u00f6ht das Risiko f\u00fcr schwerwiegende Nebenwirkungen. Dtsch Arztebl 109:A724\u2013A725","journal-title":"Dtsch Arztebl"},{"key":"1463_CR7","unstructured":"Atkinson TJ, Schatman ME, Fudin J (2014) The damage done by the war on opioids: the pendulum has swung too far. J\u00a0Pain Res 7:265\u2013268"},{"key":"1463_CR8","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","volume":"17","author":"Attal","year":"2010","unstructured":"Attal N, Cruccu G, Baron R et\u00a0al (2010) EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 17(9):1113-e88","journal-title":"Eur J Neurol"},{"key":"1463_CR9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9343(03)00116-5","volume":"114","author":"Bennett","year":"2003","unstructured":"Bennett RM, Kamin M, Karim R, Rosenthal N (2003) Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med 114(7):537\u2013545","journal-title":"Am J Med"},{"key":"1463_CR10","first-page":"CD009796","volume":"9","author":"Bernardy","year":"2013","unstructured":"Bernardy K, Klose P, Busch AJ et\u00a0al (2013) Cognitive behavioural therapies for fibromyalgia. Cochrane Database Syst Rev 9:CD009796","journal-title":"Cochrane Database Syst Rev"},{"key":"1463_CR11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-2004-812921","volume":"29","author":"Brunnm\u00fcller","year":"2004","unstructured":"Brunnm\u00fcller U, Zeitker H, Alten R, Gromnica-IIhle\u00a0E (2004) Wirksame Schmerztherapie mit Tilidin\/Naloxon retard bei Patienten mit rheumatoider Arthritis. Akt Rheumatol 29:35\u201339","journal-title":"Akt Rheumatol"},{"key":"1463_CR12","unstructured":"Bundes\u00e4rztekammer (B\u00c4K), Kassen\u00e4rztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2011) Nationale VersorgungsLeitlinie Neuropathie bei Diabetes im Erwachsenenalter. http:\/\/www.diabetes.versorgungsleitlinien.de. Zugegriffen: 1.\u00a0Februar 2014"},{"key":"1463_CR13","unstructured":"Bundes\u00e4rztekammer (B\u00c4K), Kassen\u00e4rztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (o\u00a0J) Nationale VersorgungsLeitlinie Kreuzschmerz \u2013 Langfassung. http:\/\/www.versorgungsleitlinien.de\/themen\/kreuzschmerz. Zugegriffen: 1.\u00a0Februar 2014"},{"key":"1463_CR14","first-page":"358","volume":"Clin","author":"Callejas","year":"2003","unstructured":"Callejas Rubio JL, Fern\u00e1ndez Moyano A, Navarro Hidalgo\u00a0D, Palmero Palmero\u00a0C (2003) Percutaneous fentanyl in fibromyalgia. Med Clin (Barc) 120(9):358\u2013359","journal-title":"Med"},{"key":"1463_CR15","first-page":"CD004959","volume":"8","author":"Chaparro","year":"2013","unstructured":"Chaparro LE, Furlan AD, Deshpande A et\u00a0al (2013) Opioids compared to placebo or other treatments for chronic low-back pain. Cochrane Database Syst Rev 8:CD004959","journal-title":"Cochrane Database Syst Rev"},{"key":"1463_CR16","doi-asserted-by":"crossref","unstructured":"Chou R, Clark E, Helfand M (2003) Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review. J\u00a0Pain Symptom Manage 26:1026\u20131048","DOI":"10.1016\/j.jpainsymman.2003.03.003"},{"key":"1463_CR17","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.pain.2013.07.017","volume":"154","author":"Souto","year":"2013","unstructured":"Souto Barreto P de, Lapeyre-Mestre M, Vellas B, Rolland\u00a0Y (2013) Potential underuse of analgesics for recognized pain in nursing home residents with dementia: a cross-sectional study. Pain 154(11):2427\u20132431","journal-title":"Pain"},{"key":"1463_CR18","unstructured":"Deutsche Gesellschaft f\u00fcr Neurologie (o\u00a0J) Therapie der Migr\u00e4ne. http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/030-057l_S1_Migr%C3%A4ne_Therapie_2012_1.pdf. Zugegriffen: 1.\u00a0Februar 2014"},{"key":"1463_CR19","unstructured":"Deutsche Gesellschaft f\u00fcr Neurologie (o\u00a0J) Therapie des episodischen und chronischen Kopfschmerzes vom Spannungstyp und anderer chronischer t\u00e4glicher Kopfschmerzen. http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/030-077l_S1_Spannungskopfschmerz_Therapie_2012_1.pdf. Zugegriffen: 1.\u00a0Februar 2014"},{"key":"1463_CR20","unstructured":"Deutsche Gesellschaft f\u00fcr Neurochirurgie (o\u00a0J) Epidurale R\u00fcckenmarkstimulation zur Therapie chronischer Schmerzen. http:\/\/www.awmf.org\/leitlinien\/detail\/ll\/041-002.html. Zugegriffen: 1.\u00a0Februar 2014"},{"key":"1463_CR21","unstructured":"Deutsche Gesellschaft f\u00fcr Orthop\u00e4die und Orthop\u00e4dische Chirurgie (DGOOC), Berufsverband der \u00c4rzte f\u00fcr Orthop\u00e4die (BVO) (o\u00a0J) Leitlinie Koxarthrose. http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/033-001l_S3_Koxarthrose_2009-11.pdf. Zugegriffen: 1.\u00a0Februar 2014"},{"key":"1463_CR22","unstructured":"Deutsche Gesellschaft f\u00fcr Psychosomatische Frauenheilkunde und Geburtshilfe (DGPfG) (o\u00a0J) Leitlinie chronischer Unterbauchschmerz der Frau. http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/016-001l_abgelaufen.pdf. Zugegriffen: 1.\u00a0Februar 2014"},{"key":"1463_CR23","unstructured":"Deutsche Gesellschaft f\u00fcr Psychosomatische Medizin und \u00e4rztliche Psychotherapie (o\u00a0J) S3 Leitlinie Umgang mit Patienten mit nicht-spezifischen, funktionellen und somatoformen K\u00f6rperbeschwerden. http:\/\/www.awmf.org\/leitlinien\/detail\/ll\/051-001.html. Zugegriffen: 1.\u00a0Februar 2014"},{"key":"1463_CR24","unstructured":"Deutsche Gesellschaft f\u00fcr Rheumatologie (o\u00a0J) Management der fr\u00fchen rheumatoiden Arthritis. http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/060-002l_S3_Management_fr%C3%BChe_rheumatoide_Arthritis_2011-10.pdf. Zugegriffen: 1.\u00a0Februar 2014"},{"key":"1463_CR25","unstructured":"Deutsches Institut f\u00fcr Medizinische Dokumentation und Information (o\u00a0J) OPS 2013. https:\/\/www.dimdi.de\/static\/de\/klassi\/ops\/index.htm. Zugegriffen: 1.\u00a0Februar 2014"},{"key":"1463_CR26","doi-asserted-by":"crossref","unstructured":"Dworkin RH, Turk DC, Wyrwich KW et\u00a0al (2008) Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J\u00a0Pain 9(2):105\u2013121. Zugegriffen: 1.\u00a0Februar 2014","DOI":"10.1016\/j.jpain.2007.09.005"},{"key":"1463_CR27","first-page":"898493","volume":"2013","author":"Fitzcharles","year":"2013","unstructured":"Fitzcharles MA, Faregh N, Ste-Marie PA, Shir\u00a0Y (2013) Opioid use in fibromyalgia is associated with negative health related measures in a prospective cohort study. Pain Res Treat 2013:898493","journal-title":"Pain Res Treat"},{"key":"1463_CR28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ajim.21998","volume":"55","author":"Franklin","year":"2012","unstructured":"Franklin GM, Mai J, Turner J et\u00a0al (2012) Bending the prescription opioid dosing and mortality curves: impact of the Washington State opioid dosing guideline. Am J Ind Med 55(4):325\u2013331","journal-title":"Am J Ind Med"},{"key":"1463_CR29","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1503\/cmaj.100187","volume":"182","author":"Furlan","year":"2010","unstructured":"Furlan AD, Reardon R, Weppler C, National Opioid Use Guideline Group (2010) Opioids for chronic noncancer pain: a new Canadian practice guideline. CMAJ 182(9):923\u2013930","journal-title":"CMAJ"},{"key":"1463_CR30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/pds.2164","volume":"21","author":"Garbe","year":"2012","unstructured":"Garbe E, Jobski K, Schmid U (2012) Utilisation of transdermal fentanyl in Germany from 2004 to 2006. Pharmacoepidemiol Drug Saf 21:191\u2013198","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1463_CR31","first-page":"CD010692","volume":"6","author":"Gaskell","year":"2014","unstructured":"Gaskell H, Moore RA, Derry S, Stannard\u00a0C (2014) Oxycodone for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 6:CD010692","journal-title":"Cochrane Database Syst Rev"},{"key":"1463_CR32","doi-asserted-by":"crossref","unstructured":"George JA, Kost-Byerly S, Monitto CL (2013) Opioid therapy in children and adolescents: a physician\u2019s guide to risk assessment, monitoring, and mitigation of abuse. J\u00a0Opioid Manag 9(5):357\u2013368","DOI":"10.5055\/jom.2013.0178"},{"key":"1463_CR33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00482-006-0491-6","volume":"20","author":"Hampel","year":"2006","unstructured":"Hampel C, Schenk M, G\u00f6bel H et\u00a0al (2006) Pain therapy in addicted patients. Schmerz 20(5):445\u2013457","journal-title":"Schmerz"},{"key":"1463_CR34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3810\/pgm.2013.07.2690","volume":"125","author":"Harden","year":"2013","unstructured":"Harden RN, Kaye AD, Kintanar T, Argoff\u00a0CE (2013) Evidence-based guidance for the management of postherpetic neuralgia in primary care. Postgrad Med 125(4):191\u2013202","journal-title":"Postgrad Med"},{"key":"1463_CR35","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/ar3002","volume":"12","author":"H\u00e4user","year":"2010","unstructured":"H\u00e4user W, Klose P, Langhorst J et\u00a0al (2010) Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials. Arthritis Res Ther 12(3):R79","journal-title":"Arthritis Res Ther"},{"key":"1463_CR36","first-page":"CD010292","volume":"1","author":"H\u00e4user","year":"2013","unstructured":"H\u00e4user W, Urr\u00fatia G, Tort S et\u00a0al (2013) Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. Cochrane Database Syst Rev 1:CD010292","journal-title":"Cochrane Database Syst Rev"},{"key":"1463_CR37","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00482-013-1340-z","volume":"27","author":"H\u00e4user","year":"2013","unstructured":"H\u00e4user W, Marschall U, L\u2019hoest H et\u00a0al (2013) Administrative prevalence, treatment and costs of somatoform pain disorder. Analysis of data of the BARMER GEK for the years 2008\u20132010. Schmerz 27(4):380\u2013386","journal-title":"Schmerz"},{"key":"1463_CR38","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/1471-2458-14-352","volume":"14","author":"H\u00e4user","year":"2014","unstructured":"H\u00e4user W, Wolfe F, Henningsen P et\u00a0al (2014) Untying chronic pain: prevalence and societal burden of chronic pain stages in the general population \u2013 a cross-sectional survey. BMC Public Health 14:352","journal-title":"BMC Public Health"},{"key":"1463_CR39","unstructured":"H\u00e4user W, Bernardy K, Maier C (2014) Langzeitopioidtherapie bei chronischem nicht-tumorbedingtem Schmerz. Systematische \u00dcbersicht und Metaanalyse der Wirksamkeit, Vertr\u00e4glichkeit und Sicherheit in offenen Anschlussstudien \u00fcber mindestens 26\u00a0Wochen. Schmerz. dx.doi.org\/10.1007\/s00482-014-1452-0"},{"key":"1463_CR40","first-page":"CD000335","volume":"3","author":"Hayden","year":"2005","unstructured":"Hayden JA, Tulder MW van, Malmivaara A, Koes\u00a0BW (2005) Exercise therapy for treatment of non-specific low back pain. Cochrane Database Syst Rev 3:CD000335","journal-title":"Cochrane Database Syst Rev"},{"key":"1463_CR41","first-page":"363","volume":"34","author":"Hoell","year":"2011","unstructured":"Hoell I, Havemann-Reinecke U (2011) Pregnant opioid addicted patients and additional drug intake. Part\u00a0I. Toxic effects and therapeutic consequences. Med Monatsschr Pharm 34(10):363\u2013374","journal-title":"Med Monatsschr Pharm"},{"key":"1463_CR42","first-page":"418","volume":"34","author":"Hoell","year":"2011","unstructured":"Hoell I, Amanzada A, Degner D, Havemann-Reinecke\u00a0U (2011) Pregnant opioid addicted patients and additional drug intake. Part\u00a0II: comorbidity and their therapy. Med Monatsschr Pharm 34(11):418\u2013425","journal-title":"Med Monatsschr Pharm"},{"key":"1463_CR43","doi-asserted-by":"crossref","unstructured":"Hoffmann JC, Preiss JC, Autschbach F et\u00a0al (2008) Clinical practice guideline on diagnosis and treatment of Crohn\u2019s disease. Z\u00a0Gastroenterol 46(9):1094\u20131146","DOI":"10.1055\/s-2008-1027796"},{"key":"1463_CR44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/j.1532-2149.2012.00170.x","volume":"17","author":"Itz","year":"2013","unstructured":"Itz CJ, Geurts JW, Kleef M van, Nelemans\u00a0P (2013) Clinical course of non-specific low back pain: a systematic review of prospective cohort studies set in primary care. Eur J Pain 17(1):5\u201315","journal-title":"Eur J Pain"},{"key":"1463_CR45","doi-asserted-by":"crossref","unstructured":"Kissin I (2013) Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety? J\u00a0Pain Res 6:513\u2013529","DOI":"10.2147\/JPR.S47182"},{"key":"1463_CR46","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/AJP.0b013e31827c7cf6","volume":"29","author":"Krumova","year":"2013","unstructured":"Krumova EK, Bennemann P, Kindler D et\u00a0al (2013) Low pain intensity after opioid withdrawal as a first step of a comprehensive pain rehabilitation program predicts long-term nonuse of opioids in chronic noncancer pain. Clin J Pain 29(9):760\u2013769","journal-title":"Clin J Pain"},{"key":"1463_CR47","unstructured":"Lauche M, Klose P, Radbruch L et\u00a0al (2014) Opioide bei chronischen nicht-tumorbedingten Schmerzen \u2013 gibt es Unterschiede? Systematische \u00dcbersicht und Metaanalyse der Wirksamkeit, Vertr\u00e4glichkeit und Sicherheit in randomisierten Direktvergleichen von Opioiden \u00fcber mindestens 4\u00a0Wochen. Schmerz. dx.doi.org\/10.1007\/s00482-014-1432-4"},{"key":"1463_CR48","doi-asserted-by":"crossref","unstructured":"Layer P, Andresen V, Pehl C et\u00a0al (2011) Irritable bowel syndrome: German consensus guidelines on definition, pathophysiology and management. Z\u00a0Gastroenterol 49(2):237\u2013293","DOI":"10.1055\/s-0029-1245976"},{"key":"1463_CR49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.36076\/ppj.2011\/14\/145","volume":"14","author":"Lee","year":"2011","unstructured":"Lee M, Silverman SM, Hansen H et\u00a0al (2011) A comprehensive review of opioid-induced hyperalgesia. Pain Physician 14(2):145\u2013161","journal-title":"Pain Physician"},{"key":"1463_CR50","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ajg.2012.406","volume":"108","author":"Long","year":"2013","unstructured":"Long MD, Martin C, Sandler RS, Kappelman\u00a0MD (2013) Increased risk of pneumonia among patients with inflammatory bowel disease. Am J Gastroenterol 108(2):240\u2013248","journal-title":"Am J Gastroenterol"},{"key":"1463_CR51","first-page":"e97","volume":"57","author":"Mailis-Gagnon","year":"2011","unstructured":"Mailis-Gagnon A, Lakha SF, Ou T et\u00a0al (2011) Chronic noncancer pain: characteristics of patients prescribed opioids by community physicians and referred to a tertiary pain clinic. Can Fam Physician 57(3):e97\u2013e105","journal-title":"Can Fam Physician"},{"key":"1463_CR52","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/AJP.0b013e3182385332","volume":"28","author":"Mailis-Gagnon","year":"2012","unstructured":"Mailis-Gagnon A, Lakha SF, Furlan A et\u00a0al (2012) Systematic review of the quality and generalizability of studies on the effects of opioids on driving and cognitive\/psychomotor performance. Clin J Pain 28(6):542\u2013555","journal-title":"Clin J Pain"},{"key":"1463_CR53","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s00482-011-1079-3","volume":"25","author":"Marschall","year":"2011","unstructured":"Marschall U, Arnold B, H\u00e4user W (2011) Treatment and healthcare costs of fibromyalgia syndrome in Germany: analysis of the data of the Barmer health insurance (BEK) from 2008\u20132009. Schmerz 25(4):402\u2013404, 406\u2013410","journal-title":"Schmerz"},{"key":"1463_CR54","first-page":"387","volume":"110","author":"Mayerle","year":"2013","unstructured":"Mayerle J, Hoffmeister A, Werner J et\u00a0al (2013) Chronic pancreatitis-definition, etiology, investigation and treatment. Dtsch Arztebl Int 110(22):387\u2013393","journal-title":"Dtsch Arztebl Int"},{"key":"1463_CR55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40122-014-0023-5","volume":"3","author":"Mercier","year":"2014","unstructured":"Mercier F, Claret L, Prins K, Bruno\u00a0R (2014) A model-based meta-analysis to compare efficacy and tolerability of tramadol and tapentadol for the treatment of chronic non-malignant pain. Pain Ther 3(1):31\u201344","journal-title":"Pain Ther"},{"key":"1463_CR56","doi-asserted-by":"crossref","unstructured":"Miller M, St\u00fcrmer T, Azrael D et\u00a0al (2011) Opioid analgesics and the risk of fractures in older adults with arthritis. J\u00a0Am Geriatr Soc 59(3):430\u2013438","DOI":"10.1111\/j.1532-5415.2011.03318.x"},{"key":"1463_CR57","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1055\/s-0033-1349447","volume":"138","author":"M\u00fcller-Lissner","year":"2013","unstructured":"M\u00fcller-Lissner S (2013) Opiate induced constipation \u2013 mechanisms, relevance and treatment. Dtsch Med Wochenschr 138(43):2207\u20132211","journal-title":"Dtsch Med Wochenschr"},{"key":"1463_CR58","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1185\/03007995.2011.621935","volume":"27","author":"M\u00fcller-Schwefe","year":"2011","unstructured":"M\u00fcller-Schwefe GH (2011) European survey of chronic pain patients: results for Germany. Curr Med Res Opin 27(11):2099\u20132106","journal-title":"Curr Med Res Opin"},{"key":"1463_CR59","first-page":"2","volume":"27","author":"M\u00fcller-Schwefe","year":"2011","unstructured":"M\u00fcller-Schwefe GHH (2011) Die Scheiterhaufen brennen wieder. Schmerztherapie 27:2\u20133","journal-title":"Schmerztherapie"},{"key":"1463_CR60","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1385\/IJGC:27:3:235","volume":"27","author":"Niemann","year":"2000","unstructured":"Niemann T, Madsen LG, Larsen S, Thorsgaard\u00a0N (2000) Opioid treatment of painful chronic pancreatitis. Int J Pancreatol 27(3):235\u2013240","journal-title":"Int J Pancreatol"},{"key":"1463_CR61","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685.x","volume":"11","author":"O","year":"2010","unstructured":"O\u2019Brien EM, Staud RM, Hassinger AD et\u00a0al (2010) Patient-centered perspective on treatment outcomes in chronic pain. Pain Med 11(1):6\u201315","journal-title":"Pain Med"},{"key":"1463_CR62","doi-asserted-by":"crossref","unstructured":"O\u2019Donnell JB, Ekman EF, Spalding WM et\u00a0al (2009) The effectiveness of a weak opioid medication versus a cyclo-oxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug in treating flare-up of chronic low-back pain: results from two randomized, double-blind, 6-week studies. J\u00a0Int Med Res 37(6):1789\u20131802","DOI":"10.1177\/147323000903700615"},{"key":"1463_CR63","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1053\/j.gastro.2011.04.003","volume":"141","author":"Olesen","year":"2011","unstructured":"Olesen SS, Bouwense SA, Wilder-Smith OH et\u00a0al (2011) Pregabalin reduces pain in patients with chronic pancreatitis in a randomized, controlled trial. Gastroenterology 141(2):536\u2013543","journal-title":"Gastroenterology"},{"key":"1463_CR64","unstructured":"Peng X, Robinson RL, Mease P et\u00a0al (2014) Long-term evaluation of opioid treatment in fibromyalgia. Clin J Pain (im Druck)"},{"key":"1463_CR65","doi-asserted-by":"crossref","unstructured":"Pergolizzi J, Larry M, Foster D et\u00a0al (2014) The prevalence of opioid-related major potential drug-drug interactions and their impact on health care costs in chronic pain patients. J\u00a0Manag Care Pharm 20:467\u2013476","DOI":"10.18553\/jmcp.2014.20.5.467"},{"key":"1463_CR66","unstructured":"Petzke F, Sommer C, Welsch P et\u00a0al (2014) Opioide bei chronischem Kreuzschmerz. Systematische \u00dcbersicht und Metaanalyse der Wirksamkeit, Vertr\u00e4glichkeit und Sicherheit in randomisierten, placebokontrollierten Studien \u00fcber mindestens 4\u00a0Wochen. Schmerz. dx.doi.org\/10.1007\/s00482-014-1449-8"},{"key":"1463_CR67","first-page":"161","volume":"35","author":"Petri","year":"2014","unstructured":"Petri H (2014) Das Interaktionspotenzial niederpotenter Opioide. Krankenhauspharmazie 35:161\u2013163","journal-title":"Krankenhauspharmazie"},{"key":"1463_CR68","first-page":"169","volume":"35","author":"Petri","year":"2014","unstructured":"Petri H (2014) Das Interaktionspotenzial hochpotenter Opioide. Krankenhauspharmazie 35:169\u2013171","journal-title":"Krankenhauspharmazie"},{"key":"1463_CR69","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1533-2500.2009.00320.x","volume":"9","author":"Rauck","year":"2009","unstructured":"Rauck RL (2009) What is the case for prescribing long-acting opioids over shortacting opioids for patients with chronic pain? A critical review. Pain Pract 9:468\u2013479","journal-title":"Pain Pract"},{"key":"1463_CR70","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00482-009-0839-9","volume":"23","author":"Reinecke","year":"2009","unstructured":"Reinecke H, Sorgatz H, German Society for the Study of Pain (DGSS) (2009) S3\u00a0guideline LONTS. Long-term administration of opioids for non-tumor pain. Schmerz 23(5):440\u2013447","journal-title":"Schmerz"},{"key":"1463_CR71","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.pain.2013.04.015","volume":"154","author":"Reda","year":"2013","unstructured":"Reda H, Greene K, Rice FL et\u00a0al (2013) Natural history of herpes zoster: late follow-up of 3.9\u00a0years (n\u2009=\u200943) and 7.7\u00a0years (n\u2009=\u200910). Pain 154:2227\u20132233","journal-title":"Pain"},{"key":"1463_CR72","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/archinte.166.2.155","volume":"166","author":"Rief","year":"2006","unstructured":"Rief W, Avorn J, Barsky AJ (2006) Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects. Arch Intern Med 166(2):155\u2013160","journal-title":"Arch Intern Med"},{"key":"1463_CR73","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1185\/03007995.2011.611494","volume":"27","author":"Riemsma","year":"2011","unstructured":"Riemsma R, Forbes C, Harker J et\u00a0al (2011) Systematic review of tapentadol in chronic severe pain. Curr Med Res Opin 27(10):1907\u20131930","journal-title":"Curr Med Res Opin"},{"key":"1463_CR74","doi-asserted-by":"crossref","unstructured":"Rubinstein A, Carpenter DM (2014) Elucidating risk factors for androgen deficiency associated with daily opioid use. Am J Med (im Druck)","DOI":"10.1016\/j.amjmed.2014.07.015"},{"key":"1463_CR75","doi-asserted-by":"crossref","unstructured":"Russell IJ, Kamin M, Bennett RM et\u00a0al (2000) Efficacy of tramadol in treatment of pain in fibromyalgia. J\u00a0Clin Rheumatol 6(5):250\u2013257","DOI":"10.1097\/00124743-200010000-00003"},{"key":"1463_CR76","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5737\/1181912x234236240","volume":"J","author":"Ruston","year":"2013","unstructured":"Ruston T, Hunter K, Cummings G, Lazarescu\u00a0A (2013) Efficacy and side-effect profiles of lactulose, docusate sodium, and sennosides compared to PEG in opioid-induced constipation: a systematic review. Can Oncol Nurs\u00a0J 23(4):236\u2013246","journal-title":"Can Oncol Nurs"},{"key":"1463_CR77","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1055\/s-0030-1255344","volume":"45","author":"Sabatowski","year":"2010","unstructured":"Sabatowski R, Kaiser U, Gossrau G (2010) Opioids in the management of chronic pain and driving ability. Anasthesiol Intensivmed Notfallmed Schmerzther 45(6):384\u2013385","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"1463_CR78","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/papr.12149","volume":"14","author":"Sabatowski","year":"2014","unstructured":"Sabatowski R, Mordenti G, Miceli L (2014) Opioids and driving ability: current data do not support one opioid being more favorable than another. Pain Pract 14(2):196\u2013197","journal-title":"Pain Pract"},{"key":"1463_CR79","unstructured":"Schaefert R, Sommer C, Welsch P et\u00a0al (2014) Opioide bei chronischem Arthroseschmerz. Systematische \u00dcbersicht und Metaanalyse der Wirksamkeit, Vertr\u00e4glichkeit und Sicherheit in randomisierten, placebokontrollierten Studien \u00fcber mindestens 4\u00a0Wochen. Schmerz. dx.doi.org\/10.1007\/s00482-014-1451-1"},{"key":"1463_CR80","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s40266-012-0001-8","volume":"29","author":"Scherder","year":"2012","unstructured":"Scherder EJ, Plooij B (2012) Assessment and management of pain, with particular emphasis on central neuropathic pain, in moderate to severe dementia. Drugs Aging 29(9):701\u2013706","journal-title":"Drugs Aging"},{"key":"1463_CR81","first-page":"45","volume":"110","author":"Schubert","year":"2013","unstructured":"Schubert I, Ihle P, Sabatowski R (2013) Increase in opiate prescription in Germany between 2000 and 2010: a study based on insurance data. Dtsch Arztebl Int 110(4):45\u201351","journal-title":"Dtsch Arztebl Int"},{"key":"1463_CR82","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2013.09.074","volume":"722","author":"Smith","year":"2014","unstructured":"Smith HS, Laufer A (2014) Opioid induced nausea and vomiting. Eur J Pharmacol 722:67\u201378","journal-title":"Eur J Pharmacol"},{"key":"1463_CR83","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1001\/archinternmed.2010.450","volume":"170","author":"Solomon","year":"2010","unstructured":"Solomon DH, Rassen JA, Glynn RJ et\u00a0al (2010) The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med 170(22):1979\u20131986","journal-title":"Arch Intern Med"},{"key":"1463_CR84","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00482-012-1172-2","volume":"26","author":"Sommer","year":"2012","unstructured":"Sommer C, H\u00e4user W, Alten R et\u00a0al (2012) Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline. Schmerz 26(3):297\u2013310","journal-title":"Schmerz"},{"key":"1463_CR85","doi-asserted-by":"crossref","unstructured":"Sommer C, Welsch P, Petzke F et\u00a0al (2014) Opioide bei chronischem neuropathischem Schmerz. Systematische \u00dcbersicht und Metaanalyse der Wirksamkeit, Vertr\u00e4glichkeit und Sicherheit in randomisierten, placebokontrollierten Studien \u00fcber mindestens 4\u00a0Wochen. Schmerz. dx.doi.org\/10.1007\/s00482-014-1455-x","DOI":"10.1007\/s00482-014-1455-x"},{"key":"1463_CR86","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.clp.2013.05.015","volume":"40","author":"Stanhope","year":"2013","unstructured":"Stanhope TJ, Gill LA, Rose C (2013) Chronic opioid use during pregnancy: maternal and fetal implications. Clin Perinatol 40(3):337\u2013350","journal-title":"Clin Perinatol"},{"key":"1463_CR87","unstructured":"Substance Abuse and Mental Health Services Administration (2011) Managing chronic pain in adults with or in recovery from substance use disorders. Treatment Improvement Protocol (TIP) Series\u00a054. HHS Publication No.\u00a0(SMA) 12-4671. Substance Abuse and Mental Health Services Administration, Rockville"},{"key":"1463_CR88","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.pain.2013.09.009","volume":"154","author":"Sullivan","year":"2013","unstructured":"Sullivan MD, Howe CQ (2013) Opioid therapy for chronic pain in the United States: promises and perils. Pain 154:S94\u2013S100","journal-title":"Pain"},{"key":"1463_CR89","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1474-4422(13)70239-4","volume":"12","author":"Trenkwalder","year":"2013","unstructured":"Trenkwalder C, Bene\u0161 H, Grote L et\u00a0al (2013) Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension. Lancet Neurol 12(12):1141\u20131150","journal-title":"Lancet Neurol"},{"key":"1463_CR90","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/0003-4819-155-5-201109060-00011","volume":"155","author":"Von","year":"2011","unstructured":"Von Korff M, Kolodny A, Deyo RA, Chou\u00a0R (2011) Long-term opioid therapy reconsidered. Ann Intern Med 155(5):325\u2013328","journal-title":"Ann Intern Med"},{"key":"1463_CR91","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2165\/11317200-000000000-00000","volume":"48","author":"Walter","year":"2009","unstructured":"Walter C, Felden L, L\u00f6tsch J (2009) Bioequivalence criteria for transdermal fentanyl generics: do these need a relook? Clin Pharmacokinet 48(10):625\u2013633","journal-title":"Clin Pharmacokinet"},{"key":"1463_CR92","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/j.1526-4637.2011.01276.x","volume":"12","author":"Wang","year":"2011","unstructured":"Wang H, Akbar M, Weinsheimer N et\u00a0al (2011) Longitudinal observation of changes in pain sensitivity during opioid tapering in patients with chronic low-back pain. Pain Med 12(12):1720\u20131726","journal-title":"Pain Med"},{"key":"1463_CR93","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pain.2013.10.006","volume":"155","author":"Waterschoot","year":"2014","unstructured":"Waterschoot FP, Dijkstra PU, Hollak N et\u00a0al (2014) Dose or content? Effectiveness of pain rehabilitation programs for patients with chronic low back pain: a systematic review. Pain 155(1):179\u2013189","journal-title":"Pain"},{"key":"1463_CR94","unstructured":"Welsch P, Sommer C, Schiltenwolf M, H\u00e4user\u00a0W (2014) Opioide bei chronischen nicht-tumorbedingten Schmerzen \u2013 sind sie Nichtopioidanalgetika \u00fcberlegen? Systematische \u00dcbersicht und Metaanalyse der Wirksamkeit, Vertr\u00e4glichkeit und Sicherheit in randomisierten Direktvergleichen von Opioiden und Nichtopioidanalgetika \u00fcber mindestens 4\u00a0Wochen. Schmerz. dx.doi.org\/10.1007\/s00482-014-1436-0"},{"key":"1463_CR95","unstructured":"Werber A, Marschall U, L\u2019hoest H et\u00a0al (2014) Opioid therapy in the treatment of chronic pain conditions in Germany. Pain Physician (zur Publikation angenommen)"},{"key":"1463_CR96","first-page":"CD003113","volume":"11","author":"Whittle","year":"2011","unstructured":"Whittle SL, Richards BL, Husni E, Buchbinder\u00a0R (2011) Opioid therapy for treating rheumatoid arthritis pain. Cochrane Database Syst Rev 11:CD003113","journal-title":"Cochrane Database Syst Rev"},{"key":"1463_CR97","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1533-2500.2010.00397.x","volume":"10","author":"Wild","year":"2010","unstructured":"Wild JE, Grond S, Kuperwasser B et\u00a0al (2010) Long-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis pain. Pain Pract 10(5):416\u2013427","journal-title":"Pain Pract"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-014-1463-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00482-014-1463-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-014-1463-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T12:13:33Z","timestamp":1651061613000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00482-014-1463-x"}},"subtitle":["Langzeitanwendung von Opioiden bei chronischen nicht-tumorbedingten Schmerzen","Long-term opioid therapy for chronic noncancer pain"],"short-title":[],"issued":{"date-parts":[[2015,1,25]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["1463"],"URL":"https:\/\/doi.org\/10.1007\/s00482-014-1463-x","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,25]]}}}